Data from experimental animal models of AD showed that natural and synthetic cannabinoids downregulate inflammatory responses mediated by immune cells
Library Categories
CURATED RESEARCH LIBRARY
CATEGORY : Immunology
Immune Responses Regulated by Cannabidiol
Cannabidiol (CBD) as Epidiolex® (GW Pharmaceuticals) was recently approved by the U.S. Food and Drug Administration (FDA) to treat rare
Canine immune cells express high levels of CB1 and CB2 cannabinoid receptors and cannabinoid-mediated alteration of canine cytokine production is vehicle-dependent
With the increased popularity and societal acceptance of marijuana and cannabidiol (CBD) use in humans, there is an interest in
Potential to use cannabinoids as adjunct therapy for dexamethasone: An in vitro study with canine peripheral blood mononuclear cells
Dexamethasone (dex) is a potent glucocorticoid used to treat a variety of diseases. It is widely used in veterinary medicine
Cannabidiol Suppresses Cytokine Storm and Protects Against Cardiac and Renal Injury Associated with Sepsis
Background: Cytokine release syndrome, also termed “cytokine storm,” is the leading cause of morbidity and mortality among patients with various
Feeding treats containing cannabidiol (CBD) did not alter canine immune response to immunization with a novel antigen
Due to the potential risk for cannabidiol (CBD) to negatively impact the immune system, the objective of the current study
Cellular distribution of cannabinoid-related receptors TRPV1, PPAR-gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia
Cannabinoid-related receptors were distributed in the sensory neurons (TRPV1, PPARγ, GPR55 and GPR3), SGCs (TRPV1, PPARγ and GPR55), macrophages (GPR55)
The fatty acid amide hydrolase inhibitor URB597 modulates splenic catecholamines in chronically stressed female and male rats
Abstract The changes in sympathetic innervations in lymphoid organs could be a key factor in immune dysregulation. The endocannabinoid system
© 2025 · Veterinary Cannabis Society